Michael Jameson

University of Auckland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (4)

Richard J. Epstein

University of New South Wales

Eugene J. Koay

UNITED STATES

Tarik Sammour

Associate Professor

Royal Adelaide Hospital

P. Quaglino

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Jameson

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (4)

Richard J. Epstein

Eugene J. Koay

Tarik Sammour

P. Quaglino

Make your next move.

Michael Jameson

Research Interests

Explore related searches

Contact this professor

Articles (10)

Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022

TNT: Raising more questions than answers?

Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial

Ethnic Differences in Cancer Rates among Adults with Type 2 Diabetes in New Zealand from 1994 to 2018

Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series

Artificial Intelligence Support for Skin Lesion Triage in Primary Care and Dermatology

Remote Skin Cancer Diagnosis: Adding Images to Electronic Referrals Is More Efficient Than Wait-Listing for a Nurse-Led Imaging Clinic

Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long‐term events

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Collaborators (4)

Richard J. Epstein

Eugene J. Koay

Tarik Sammour

P. Quaglino

Make your next move.